• Ourofino Saúde Animal Participações’ fiscal council met Nov. 11, 2026, to review quarterly financial statements.
• The council endorsed publication of standalone and consolidated financial statements for the quarter and nine months ended Sept. 30, 2026.
• Directors had approved the statements Nov. 10; KPMG issued an unqualified review report.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ourofino Saúde Animal Participações SA published the original content used to generate this news brief on November 12, 2026, and is solely responsible for the information contained therein.